Marcus Dawn A, Bernstein Cheryl D, Haq Adeel, Breuer Paula
Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA, USA.
Musculoskeletal Care. 2014 Jun;12(2):74-81. doi: 10.1002/msc.1056. Epub 2013 Jul 23.
Fibromyalgia is associated with substantial functional disability. Current drug and non-drug treatments result in statistically significant but numerically small improvements in typical numeric measures of pain severity and fibromyalgia impact.
The aim of the present study was to evaluate additional measures of pain severity and functional outcome that might be affected by fibromyalgia treatment.
This retrospective review evaluated outcomes from 274 adults with fibromyalgia who participated in a six-week, multidisciplinary treatment programme. Pain and function were evaluated on the first and final treatment visit. Pain was evaluated using an 11-point numerical scale to determine clinically meaningful pain reduction (decrease ≥ 2 points) and from a pain drawing. Function was evaluated by measuring active range of motion (ROM), walking distance and speed, upper extremity exercise repetitions, and self-reports of daily activities.
Numerical rating scores for pain decreased by 10-13% (p < 0.01) and Fibromyalgia Impact Questionnaire (FIQ) scores decreased by 20% (p < 0.001). More substantial improvements were noted when using alternative measures. Clinically meaningful pain relief was achieved by 37% of patients, and the body area affected by pain decreased by 31%. ROM showed significant improvements in straight leg raise and cervical motion, without improvements in lumbar ROM. Daily walking distance increased fourfold and arm exercise repetitions doubled.
Despite modest albeit statistically significant improvements in standard measures of pain severity and the FIQ, more substantial pain improvement was noted when utilizing alternative measures of pain and functional improvement. Alternative symptom assessment measures might be important outcome measures to include in drug and non-drug studies to better understand fibromyalgia treatment effectiveness.
纤维肌痛与严重的功能障碍相关。目前的药物和非药物治疗在疼痛严重程度和纤维肌痛影响的典型数字测量方面,虽在统计学上有显著改善,但数值上改善较小。
本研究旨在评估可能受纤维肌痛治疗影响的疼痛严重程度和功能结局的其他测量方法。
这项回顾性研究评估了274名参与为期六周多学科治疗项目的成年纤维肌痛患者的结局。在首次和最后一次治疗就诊时评估疼痛和功能。使用11点数字量表评估疼痛,以确定具有临床意义的疼痛减轻(降低≥2分),并通过疼痛图进行评估。通过测量主动活动范围(ROM)、步行距离和速度、上肢运动重复次数以及日常活动的自我报告来评估功能。
疼痛的数字评分得分下降了10 - 13%(p < 0.01),纤维肌痛影响问卷(FIQ)得分下降了20%(p < 0.001)。使用替代测量方法时,改善更为显著。37%的患者实现了具有临床意义的疼痛缓解,疼痛影响的身体面积减少了31%。ROM在直腿抬高和颈椎活动方面有显著改善,腰椎ROM无改善。每日步行距离增加了四倍,手臂运动重复次数增加了一倍。
尽管在疼痛严重程度的标准测量和FIQ方面有适度的统计学显著改善,但在使用疼痛和功能改善的替代测量方法时,疼痛改善更为显著。替代症状评估方法可能是药物和非药物研究中重要的结局测量方法,可以更好地了解纤维肌痛的治疗效果。